Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

Interview with Dr. Elizabeth Mittendorf

Loading...

Sign in or sign up now!
75 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon
Ratings have been disabled for this video.

Uploaded by on Oct 16, 2008

Dr. Elizabeth Mittendorf discusses findings that suggest HER2-positive breast tumors can convert to HER2-negative status in women receiving
chemotherapy and the HER2-targeting
drug trastuzumab (Herceptin). Kerri Wachter of Elsevier Global Medical News (EGMN) interviews Dr. Mittendorf at a breast cancer symposium sponsored by the American Society for Clinical Oncology.

All Comments

Adding comments has been disabled for this video.

0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more